TCG Crossover Management »

Liquidia Technologies shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Liquidia Technologies (LQDA) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Liquidia Technologies

Tip: Access up to 7 years of quarterly data

All positions including Liquidia Technologies held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liquidia Technologies by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $39M 1.7M 22.74

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Liquidia Technologies

Farallon Capital Management
Caligan Partners
BlackRock
Findell Capital Management
Vanguard Group
Susquehanna International
Goldman Sachs Group
Opaleye Management
Jane Street
Caption Management
Point72 Asset Management
State Street Corporation
TCG Crossover Management
Caprock
Geode Capital Management

View all funds holding Liquidia Technologies